Edward Eunkee Whang, MD

Adjunct Associate Professor, Surgery

Edward Eunkee Whang
ewhang1@partners.org
View full profile at BUMC

Biography

Dr. Whang, MD is a practicing Surgeon in Boston, MA. Dr. Whang graduated from University of Chicago Pritzker School of Medicine in 1991 and has been in practice for 28 years. He completed a residency at UCLA Medical Center. Dr. Whang is board certified in Surgery. Dr. Whang also practices at Boston Vamc in Jamaica Plain, MA.

Other Positions

  • VA Boston Healthcare System

Websites

Education

  • Pritzker School of Medicine, MD
  • Massachusetts Institute of Technology, BS

Publications

  • Published on 8/1/2023

    Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. Editorial Expression of Concern: Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness. Oncogene. 2023 Aug; 42(34):2589. PMID: 37468680.

    Read at: PubMed
  • Published on 7/8/2023

    Duxbury MS, Ito H, Ashley SW, Whang EE. Withdrawal: CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells. J Biol Chem. 2023 Jul; 299(7):105007. PMID: 37429045.

    Read at: PubMed
  • Published on 4/20/2023

    Foroushani S, Gaetani RS, Lin B, Chugh P, Siegel A, Whang E, Kristo G. Role Reversal Between Trainees and Surgeons: Improving Autonomy and Confidence in Surgical Residents. J Surg Res. 2023 Sep; 289:75-81. PMID: 37086599.

    Read at: PubMed
  • Published on 3/1/2023

    Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Retraction Note: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma. Oncogene. 2023 Mar; 42(12):938. PMID: 36759574.

    Read at: PubMed
  • Published on 3/1/2023

    Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Retraction Note: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene. 2023 Mar; 42(12):939. PMID: 36765147.

    Read at: PubMed
  • Published on 3/1/2023

    Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Retraction Note: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine. Oncogene. 2023 Mar; 42(14):1157. PMID: 36797340.

    Read at: PubMed
  • Published on 2/11/2023

    Ito H, Duxbury M, Zinner MJ, Ashley SW, Whang EE. Retraction notice to Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity [Surgery -September 2004, Pages 548-556]. Surgery. 2023 Apr; 173(4):1108. PMID: 36781314.

    Read at: PubMed
  • Published on 2/10/2023

    Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. Retraction notice to Read at: PubMed

  • Published on 5/6/2022

    He K, Sell NM, Chugh P, Rasic G, Collado L, Smink DS, Whang E, Kristo G. Improving the financial wellness of general surgery residents: A nationwide survey. Am J Surg. 2022 Sep; 224(3):888-892. PMID: 35545475.

    Read at: PubMed
  • Published on 5/1/2022

    Pastrana Del Valle J, Fillmore NR, Molina G, Fairweather M, Wang J, Clancy TE, Ashley SW, Urman RD, Whang EE, Gold JS. ASO Visual Abstract: Socioeconomic Disparities in Pancreas Cancer Resection and Survival in the Veterans Health Administration. Ann Surg Oncol. 2022 May; 29(5):3205. PMID: 35132489.

    Read at: PubMed

View 163 more publications: View full profile at BUMC

View all profiles